Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Fineotex Chemical LtdQ1 FY27Chemicals & Petrochemicals
Home/Stocks/Fineotex Chemical Ltd/Q1 FY27

Fineotex Chemical Ltd Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹48.6P/E: 45.1Market Cap: ₹5.5K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2
  • →Fineotex aims to achieve USD 200 million revenue from CrudeChem (CCT) segment by FY'28, doubling from approx. INR 1,000 crores in FY'26.
  • →The company expects organic growth aided by sustainability trends and replication of product lines in global markets.
  • →Texas plant has expanded capacity to 1,48,000 MTPA with current utilization around 63-65%; plans to increase utilization to peak in coming quarters.
  • →Potential exists to double production by running two shifts with minimal additional capex (~USD 1-2 million).
  • →Growth driven by increasing wallet share in oil & gas markets across USA, Canada, Venezuela, Gulf countries, Saudi Arabia, and new markets like Suriname and Guyana.
  • →Textile business expected to recover from seasonal dips; moderate growth aligned with 5-7% industry CAGR.
  • →Crude oil price fluctuations are not expected to significantly impact growth trajectory.
  • →Focus on green/sustainable chemical solutions bolsters long-term revenue expansion.

Margin guidance

Category 3
  • →Fineotex Chemicals anticipates strong revenue and profit growth driven by expanded Texas facility capacity and healthy demand in the U.S. oil and gas segment.
  • →The recently commissioned capacity expansion in Texas enhances ability to secure larger contracts, aiming for higher capacity utilization (currently ~63%).
  • →The company expects to double shift operations to boost volumes without significant additional capital (capex up to USD 1-2 million manageable).
  • →Emphasis on specialty high-margin chemical products supports sustained healthy ROCEs and EBITDA margins.
  • →EBITDA margins have improved from 14% post-acquisition to 16% in Q1 FY27, with a target to reach or exceed 18% consolidated margins.
  • →Revenue guidance includes USD 100 million in FY27 and USD 200 million in FY28 from the CrudeChem segment.
  • →Focus on inorganic growth through disciplined M&A targeting synergy and value creation.
  • →Expansion of green chemistry portfolio and technical capabilities to drive sustainable long-term growth.

3 more insights locked — sign up free to unlock

Fundraise plans

  • →Fineotex Chemicals Limited highlighted that they have a very healthy cash position and controlled working capital, indicating strong liquidity.
  • →A recent comment mentioned that any potential capital investment for capacity expansion (e.g., USD 1-2 million) would not be a major concern or game changer.
  • →The company is focused on disciplined capital deployment and cash discipline.
  • →They are proactively exploring inorganic growth opportunities but have not announced any specific upcoming fundraises through debt or equity.
  • →No explicit mention or guidance was given about current or future fundraising initiatives in the transcript.
  • →Overall, Fineotex appears well-capitalized and flexible financially, with no immediate plans for raising new capital through debt or equity disclosed as of July 2026.

Order book

Yes
  • →There is no traditional "order book" system like government tenders; orders vary with oil and gas cycles.
  • →Business depends on delivering value as per client needs, with a focus on sustainable solutions.
  • →Once a well starts production, work is generally perennial and cannot be stopped abruptly.
  • →The company experiences fluctuations due to weather and operational cycles but maintains steady demand.
  • →Strong ongoing order flow is indicated, with existing expanded capacities being utilized (~63% utilized recently).
  • →CrudeChem has a solid pipeline, and capacity expansion is expected to support higher order volumes soon.
  • →The management emphasizes focusing on customer relationships and sustainability rather than fixed order backlog.

Capex plans

Yes
  • →Fineotex Chemicals invested significantly in expanding its Texas facility, adding 69,000 MTPA capacity, increasing total capacity to 268,000 MTPA, enhancing ability to serve larger customer contracts and drive growth.
  • →The CrudeChem Group acquisition provided growth capital enabling capacity expansion and ramp-up; additional minor capex of USD 1-2 million anticipated for doubling shifts or enhancing capacity.
  • →Company remains cash disciplined with high cash on book and continues to monitor for selective inorganic growth opportunities with focus on synergy and value.
  • →Further capital infusion helped secure better pricing from suppliers, improving EBITDA margins.
  • →No major capex concerns currently; incremental capital investments are relatively small compared to growth potential.
  • →Expansion expected to enable capacity utilization to reach peak in coming quarters.
  • →Ongoing investments in R&D, production, and supplier alliances to support operational efficiency and product quality.

How does Fineotex Chemical Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Fineotex Chemical Ltd
Rev 2Mar 3
2Chemicals & Petrochemicals Company A
Rev 1Mar 2
3Chemicals & Petrochemicals Company B
Rev 2Mar 1
4Chemicals & Petrochemicals Company C
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

How does Fineotex Chemical Ltd rank in Chemicals & Petrochemicals?

Compare Fineotex Chemical Ltd against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Related research

Read the full Q1 FY27 earnings insight — Fineotex Chemical Ltd

Other quarters — Fineotex Chemical Ltd

Q4 FY26Q3 FY26Q2 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q3 FY24

Chemicals & Petrochemicals peers

Aarti Industries · Q1 FY27BASF India · Q4 FY26Deepak Fertilis. · Q1 FY27Deepak Nitrite · Q1 FY27Himadri Special · Q1 FY27
Fineotex Chemical Ltd full stock analysisChemicals & Petrochemicals sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Fineotex Chemical Ltd's management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q4 FY25 earnings call analysis →
  • Q1 FY26 earnings call analysis →
  • Q3 FY26 earnings call analysis →

Others in Chemicals & Petrochemicals this season

  • Fine Organic (Q3 FY26)

    Investment of approximately INR 700-750 crores for Phase 1. Key concall takeaways from Fine Organic's Q3 FY26 earnings call — and how it ranks against sector…

  • NOCIL (Q4 FY26)

    The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…

  • Indo Borax & Chemicals Ltd (Q4 FY26)

    175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…

  • Tanfac Inds. (Q1 FY27)

    Around 80% to 85% of the solar grade DHF plant capacity is contracted. Key concall takeaways from Tanfac Inds.'s Q1 FY27 earnings call — and how it ranks…

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF